Manufacturer's investigation conclusion.A direct correlation between (b)(6) and the reported thrombosis, hypertension, and patient conditions could not conclusively be determined through this evaluation.The reported thrombosis could not be confirmed through this evaluation as no images were submitted and no product was returned.The submitted log file captured transient pi events throughout the log file, resulting in momentary decreases in speed per design.No other atypical events were captured.The pump appeared to operate as intended.The patient remains ongoing on heartmate ii left ventricular assist system (lvas), serial number (b)(6).No product is available for investigation.The hmii ifu lists device thrombosis and hypertension as adverse events that may be associated with the use of the heartmate ii left ventricular assist system.The patient care and management section provides information on anticoagulation, including recommended inr values.This section also outlines indications of pump thrombosis, as well as how to respond to such events.The heartmate ii lvas ifu, rev.C, lists device thrombosis and hypertension as adverse events that may be associated with the use of the heartmate ii left ventricular assist system.The patient care and management section provides information on anticoagulation, including recommended inr values.This section also outlines indications of pump thrombosis, as well as how to respond to such events.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The implant kit was shipped on 29jun2015.No further information was provided.The manufacturer is closing the file on this event.
|